Effect of an anticholinergic agent on riboflavin absorption in man.
D000284:Administration, Oral; D000328:Adult; D001702:Biopharmaceutics; D002986:Clinical Trials as Topic; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology; D011413:Propantheline / Q000008:administration & dosage / Q000494:pharmacology*; D012256:Riboflavin / Q000008:administration & dosage / Q000378:metabolism* / Q000652:urine; D013268:Stimulation, Chemical
D010276:Parasympatholytics; D011413:Propantheline; D012256:Riboflavin